Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical firm dedicated to developing novel prescription drugs for the treatment of severe pain in the United States, with a specific focus on preventing opioid addiction, misuse, abuse, and overdose.
Ensysce Biosciences stock last closed at $0.45, up 1.12% from the previous day, and has decreased 78.43% in one year. It has underperformed other stocks in the Biotechnology industry by 0.57 percentage points. Ensysce Biosciences stock is currently +96.96% from its 52-week low of $0.23, and -83.53% from its 52-week high of $2.75.
At the moment, there are 19.46M shares of ENSC outstanding. The market capitalization of ENSC is $8.81M. In the last 24 hours, 391,000 ENSC shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy ENSC shares.
We believe that eToro is the best brokerage. eToro gives you:
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen your brokerage, you'll need to fill out some personal information so you can invest in ENSC today.
Now that you have filled out your info on stock market app, you need to deposit funds:
Check out the walkthrough below if you need help depositing money into your brokerage account.
After you have identified the best place to buy Ensysce Biosciences stock, it's very important to evaluate their stock before you invest, so you truly comprehend the risk and opportunity.
WallStreetZen was created to help average investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on ENSC's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ENSC's true value.
You can access more valuation analysis on ENSC's stock here.
You can dig deeper into what analysts are forecasting on the Ensysce Biosciences stock forecast page.
Over the last 12 months, insiders at ENSC have bought more shares than they have sold.
Bob G. Gower, Director of ENSC, was the latest ENSC insider to buy. They bought $198,000.00 worth of ENSC shares on Aug 7, 2026.
Dig into more about who owns ENSC stock here.
No, Ensysce Biosciences doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
You have two primary options:
Press the Open Trade button and eToro will place the order.
If you want more help investing in stocks on eToro, watch the helpful video below:
Now that you own some shares in ENSC, you'll want to stay up-to-date on your stock purchase.
Start a watchlist to get notified of the latest news about your ENSC stock.
To reiterate, here are the 6 steps to buy Ensysce Biosciences stock:
If you require a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to monitor your new investment in Ensysce Biosciences, add ENSC to your watchlist below.